Form 4: Nu Skin CEO Napierski's Performance-Based Stock Vesting

Nu Skin Enterprises CEO Ryan Napierski saw significant restricted stock units vest after the company met performance criteria, increasing his direct beneficial ownership.

Summary

• Ryan S. Napierski, President and CEO of Nu Skin Enterprises, Inc. (NUS), reported the vesting of performance-based restricted stock units (RSUs).
• On February 10, 2026, 42,970 shares of Class A Common Stock, granted on February 27, 2024, vested after the company met specific performance criteria.
• On the same date, an additional 206,988 shares of Class A Common Stock, granted on February 26, 2025, also vested due to the satisfaction of performance criteria.
• These vesting events resulted in a total of 249,958 shares being acquired by Mr. Napierski at a price of $0.00 per share.
• Following these transactions, Mr. Napierski's direct beneficial ownership of Class A Common Stock increased to 893,391 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as the vesting of performance-based RSUs indicates the company successfully met its pre-defined performance targets, aligning executive incentives with shareholder value.

Positives

• Company met performance criteria for two tranches of restricted stock units granted to the President and CEO.
• Significant increase in the CEO's direct beneficial ownership, aligning management interests with shareholders.
• The vesting of 249,958 shares indicates successful achievement of previously set corporate goals.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4, as it reports a past transaction based on previously established performance criteria.

Industry Context

StockSavvy.ai notes that performance-based restricted stock unit vesting is a common executive compensation practice across industries, aligning executive incentives with long-term company performance and shareholder value creation. This particular filing reflects the successful achievement of specific, undisclosed performance criteria by Nu Skin, which is a positive signal for the company's operational execution within the direct selling and personal care industry.

Comparison to Industry Standards

• Performance-based RSU grants are a standard component of executive compensation packages in publicly traded companies, including those in the consumer goods and direct selling sectors like Nu Skin.
• Companies such as Herbalife Nutrition Ltd. (HLF) and USANA Health Sciences, Inc. (USNA), direct competitors, also utilize similar equity incentive plans to motivate and retain key executives.
• The vesting of a substantial number of shares (249,958 total) for the CEO suggests that Nu Skin's performance metrics, while not detailed in this filing, were met, which is a positive indicator compared to companies where such targets are missed.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive alignment of CEO's interests with shareholder value due to increased equity ownership tied to performance.
• Employees: May signal a positive internal environment if company performance targets are being met.
• Management: Increased equity stake and successful achievement of performance goals.

Key Dates

Recommendation

This Form 4 reports a routine vesting of performance-based restricted stock units for the CEO, indicating the company met its internal performance targets. While positive, it does not present new fundamental information that would warrant a change in investment thesis. It reinforces a "hold" position for investors already in Nu Skin, as it confirms executive compensation is tied to and rewarded by company performance.

Keywords

Nu Skin Enterprises, NUS, Ryan Napierski, Restricted Stock Units, RSU Vesting, Insider Transaction, CEO Compensation, Performance Criteria, Beneficial Ownership, Form 4